Nystatin Oral Suspension Articles
Biota's flu drug enters Ph II trials
26 November 2007
Analysis indicates further Revlimid benefits in MM
26 November 2007
Japan stock market week to Nov 19, 2007
26 November 2007
Pfizer's Celsentri launched in the UK
26 November 2007
Takeda ads to promote Actos' lack of cardio risks
26 November 2007
Pipex gets $7.3M from warrants
26 November 2007
FDA grants Abilify priority review status
26 November 2007
Wyeth's DR Protonix gets FDA thumbs up
26 November 2007
Barr's 3rd-qtr income falls 26% on Pliva costs
26 November 2007
Roche drug combo helps Pegintron-resistant patients
21 November 2007
Watson files ANDA for generic of Bayer-Schering's Yaz
19 November 2007
FDA orders GSK to add warning to Avandia
19 November 2007
AEterna completes enrolment in Ph II NSCLC trial
19 November 2007
Merck KGaA pays Rigel $3M for Japanese right to cancer drug
19 November 2007
Celgene's Revlimid gets nod from ADEC
19 November 2007
Watson's 3rd-qtr 2007 revenue hits $594.7M
19 November 2007
Tranzyme Pharma closes new $20M financing
12 November 2007
Cytogen's 3rd-qtr loss improves 11% on sales
12 November 2007
Amira completes Ph I AM103 assessment
12 November 2007
Positive Ph IIb data for Ipsat P1A
5 November 2007
Headlines 25 years ago this week....
5 November 2007
Roche updates CellCept warning label
5 November 2007
FDA clears Barr's generic Estrostep
5 November 2007
Belinostat shows promise in range of cancer indications
5 November 2007
Strong PAH data for Tracleer plus sildenafil
29 October 2007
Novartis' Voltaren Gel cleared by FDA
29 October 2007
S-P's boceprevir boosts HCV clearance rates
29 October 2007
SCOLR and Dr Reddy's enter licensing deal
29 October 2007
Merck & Co's 3rd-qtr 2007 sales jump 12%
29 October 2007
Positive Ph II safety data on S-P's TRA
29 October 2007
Beijing Med-Pharm to market Ferriprox in China
29 October 2007
Generex signs S Africa Oral-lyn distribution deal
29 October 2007
Japan's MHLW clears Novo Nordisk's Levemir
29 October 2007
DOR's orBec gets not-approvable from FDA
29 October 2007
GSK's Hycamtin gets FDA OK
22 October 2007
Iroko buys Canadian antibiotic rights
22 October 2007
Bayer/J&J's Xarelto will drive anticoagulant market
22 October 2007
Samaritan gets $8.6M upfront from Pharmaplaz
22 October 2007
Sanofi-Aventis chief calls for volume pricing
22 October 2007
CuraGen drops mucositis drug on poor trial data
22 October 2007
Encysive launches Thelin in USA
15 October 2007
Aspreva/Roche
15 October 2007
Cosmo licenses Budesonide MMX to Ferring
15 October 2007
Accentia agrees with FDA on Revimmune trial
15 October 2007
Sirtris' SRT501 shows potential in optic neuritis model
15 October 2007
Vacc-derived polio hits Nigeria: WHO "cover up"
15 October 2007
Novartis' Aclasta cleared in the EU
15 October 2007
Watson files for generic Femcon
8 October 2007
Orexo's Sublinox shows positive results in Ph III
8 October 2007
14th annual ECCO conference hears exciting data on combination therapy with biologics
8 October 2007
X-ACT confirms Xeloda efficacy in bowel cancer
8 October 2007
EC approves Novartis' Galvus in Europe
8 October 2007
EMEA OKs smaller capsule Tamiflu
8 October 2007
Samaritan amends due date for Pharmaplaz payment
8 October 2007
Exelon gets EC OK for Alzheimer's disease
1 October 2007
Pfizer's Celsentri gets European Commission approval for patients infected with HIV-1 CCR5-tropic virus
1 October 2007
Isentress plus OBT sustains HIV suppression
1 October 2007
J&J's doripenem fares well vs NP and VAP
1 October 2007
Tibotec files etravirine NDA with FDA
1 October 2007
Encysive's Thelin launched in Spain
24 September 2007
Strong data for Merck & Co's sitagliptin plus metformin
24 September 2007
FDA clears new indication for Ortho-McNeil's Levaquin
24 September 2007
BioMarin grants exclusive data on Kuvan to Asubio
24 September 2007
Alltracel's six-month EBITDA climbs 64%
24 September 2007
Galvus boosts glycemic control in met patients
24 September 2007
First patient dosed in Ph III lubiprostone trial
24 September 2007
Dabigatran as effective in VTE as enoxaparin
24 September 2007
NCCN updates hepatobiliary cancer guidelines, adding Nexavar
17 September 2007
UPDATE: Acting CMS Administrator could remain until 2009
17 September 2007
Scottish cancer patients offered Xeloda
17 September 2007
Aranesp has no negative survival impact in SCLC
17 September 2007
Celgene
10 September 2007
Beximco starts shipping drugs to Hong Kong
10 September 2007
Catalent's deal with ALK-Abello will expand Zydis capacity
3 September 2007
SpePharm to sell Access' MuGard in Europe
3 September 2007
Barr's Portia approved and launched in Canada
3 September 2007
Alltracel to buy Synpart for 6.3M euros
3 September 2007
Ethics appro for Bone Medical's Perthoxal study
3 September 2007
Lundbeck's 2nd-qtr 2007 revenue increases 19%
3 September 2007
Novel technology for cancer pain
3 September 2007
MedPredict publishes report on RA treatment market
20 August 2007
FDA requests extension for Frova sNDA
20 August 2007
US FDA accepts GSK's Rotarix BLA for review
20 August 2007
Oncologists reluctant to switch to Tykerb
20 August 2007
Positive Ph I data for NXN-188
20 August 2007
Oral-lyn comparable to injected insulin
20 August 2007
Strong Ph III study data for BioMarin's PKU drug
20 August 2007
Actavis' generic Inderal LA gets US approval
20 August 2007
Competition in the venous thromboembolism market
20 August 2007
BioMarin's 2nd-qtr 2007 loss widens to $3.9M
20 August 2007
King's 2nd-qtr revenue rises 9%, net income falls
20 August 2007
Spectrum gets world rights to ortataxel
20 August 2007
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
